Why Healthcare Realty Trust Incorporated (HR) stock moved
Healthcare Realty Trust Incorporated (HR) shares fell 0.3% to $21.25 as of July 21, 2026, a slight decline from the prior close of $21.32. BestStocks flagged the session as a major change for HR. No single company-specific catalyst was confirmed during the move window. Below, we break down what changed for HR, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
HR fell 0.3% to $21.25
HR fell 0.3% in its latest session, moving from $21.32 to $21.25.
What it means for Healthcare Realty Trust Incorporated investors
For Healthcare Realty Trust Incorporated investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Healthcare Realty Trust Incorporated (HR) moved +0.14% from $21.29 to $21.32 on 2026-07-17, reaching a new 30-day high on modestly elevated volume (1.5x the 5-day average); Healthcare Realty Trust Incorporated (HR) moved +3.10% from $20.65 to $21.29 on July 16, 2026. Weighing against that: Negative session, down 0.3%; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $22.00, implying +3.5% upside from $21.25. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 9 days out, the next report is the most likely near-term test of the move.
HR price reaction
HR last traded at $21.25, down $0.07 (-0.33%) from the previous close of $21.32. The session traded on 1.0× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $20.16 and $21.32, and it currently sits about 94% of the way up that band.
Bullish and bearish analyst opinions on Healthcare Realty Trust Incorporated (HR)
The consensus analyst price target on Healthcare Realty Trust Incorporated (HR) is $22.00, 3.5% above the recent $21.25. Over the past 90 days analysts logged 0 upgrades, 8 maintains, and 0 downgrades. Here is how the bullish and bearish cases on HR line up.
The bullish case
- Wall Street's consensus price target of $22.00 implies +3.5% upside from $21.25.
- The Street's most bullish target is $24.00 (+12.9%).
- Healthcare Realty Trust Incorporated (HR) moved +0.14% from $21.29 to $21.32 on 2026-07-17, reaching a new 30-day high on modestly elevated volume (1.5x the 5-day average).
The bearish case
- The most bearish analyst target is $21.00 (-1.2%).
- Negative session, down 0.3%.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Jul 21, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for HR
Frequently asked questions about HR
Why did Healthcare Realty Trust Incorporated (HR) stock move?
HR fell 0.3% to $21.25. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did HR stock fall?
HR lost 0.33% ($0.07) versus the prior close of $21.32, last trading at $21.25 on 1.0× average volume.
When is Healthcare Realty Trust Incorporated's next earnings date?
HR's next earnings report is estimated for 2026-07-30 — about 9 days away.
What is the analyst price target for HR?
The consensus analyst price target for HR is $22.00, about 3.5% above the current $21.25. Over the past 90 days, analysts recorded 0 upgrades, 8 maintains, and 0 downgrades.
How BestStocks tracks HR
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared HR-specific materiality thresholds, triggering an evidence check. It draws on 6 tracked change events for HR, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 21, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.